Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1981 1
1985 1
1987 1
1988 5
1989 1
1990 2
1992 4
1993 2
1994 2
1995 5
1997 3
1998 2
1999 1
2000 3
2002 1
2003 1
2004 2
2005 1
2006 2
2007 3
2008 5
2009 1
2010 1
2011 3
2012 1
2013 4
2014 1
2015 1
2016 1
2017 1
2018 1
2021 11
2022 7
Text availability
Article attribute
Article type
Publication date

Search Results

78 results
Results by year
Filters applied: . Clear all
Page 1
Pooled Safety Results Through 1 Year of 2 Phase III Trials of Guselkumab in Patients With Psoriatic Arthritis.
Rahman P, Ritchlin CT, Helliwell PS, Boehncke WH, Mease PJ, Gottlieb AB, Kafka S, Kollmeier AP, Hsia EC, Xu XL, Shawi M, Sheng S, Agarwal P, Zhou B, Ramachandran P, Zhuang Y, McInnes IB. Rahman P, et al. Among authors: shawi m. J Rheumatol. 2021 Dec;48(12):1815-1823. doi: 10.3899/jrheum.201532. Epub 2021 May 1. J Rheumatol. 2021. PMID: 33934076 Free article. Clinical Trial.
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
McGonagle D, McInnes IB, Deodhar A, Schett G, Shawi M, Kafka S, Karyekar CS, Kollmeier AP, Hsia EC, Xu XL, Sheng S, Agarwal P, Zhou B, Ritchlin CT, Rahman P, Mease PJ. McGonagle D, et al. Among authors: shawi m. Rheumatology (Oxford). 2021 Nov 3;60(11):5337-5350. doi: 10.1093/rheumatology/keab285. Rheumatology (Oxford). 2021. PMID: 33822898 Free PMC article. Clinical Trial.
Guselkumab demonstrated an independent treatment effect in reducing fatigue after adjustment for clinical response-results from two phase 3 clinical trials of 1120 patients with active psoriatic arthritis.
Rahman P, Mease PJ, Helliwell PS, Deodhar A, Gossec L, Kavanaugh A, Kollmeier AP, Hsia EC, Zhou B, Lin X, Shawi M, Karyekar CS, Han C. Rahman P, et al. Among authors: shawi m. Arthritis Res Ther. 2021 Jul 14;23(1):190. doi: 10.1186/s13075-021-02554-3. Arthritis Res Ther. 2021. PMID: 34261541 Free PMC article. Clinical Trial.
Guselkumab, an inhibitor of the IL-23p19 subunit, provides sustained improvement in signs and symptoms of active psoriatic arthritis: 1 year results of a phase III randomised study of patients who were biologic-naïve or TNFα inhibitor-experienced.
Ritchlin CT, Helliwell PS, Boehncke WH, Soriano ER, Hsia EC, Kollmeier AP, Chakravarty SD, Zazzetti F, Subramanian RA, Xu XL, Zuraw QC, Sheng S, Jiang Y, Agarwal P, Zhou B, Zhuang Y, Shawi M, Karyekar CS, Deodhar A. Ritchlin CT, et al. Among authors: shawi m. RMD Open. 2021 Feb;7(1):e001457. doi: 10.1136/rmdopen-2020-001457. RMD Open. 2021. PMID: 33568556 Free PMC article. Clinical Trial.
Long-Term Efficacy and Safety of Guselkumab, a Monoclonal Antibody Specific to the p19 Subunit of Interleukin-23, Through Two Years: Results From a Phase III, Randomized, Double-Blind, Placebo-Controlled Study Conducted in Biologic-Naive Patients With Active Psoriatic Arthritis.
McInnes IB, Rahman P, Gottlieb AB, Hsia EC, Kollmeier AP, Xu XL, Jiang Y, Sheng S, Shawi M, Chakravarty SD, van der Heijde D, Mease PJ. McInnes IB, et al. Among authors: shawi m. Arthritis Rheumatol. 2022 Mar;74(3):475-485. doi: 10.1002/art.42010. Epub 2022 Feb 7. Arthritis Rheumatol. 2022. PMID: 34719872 Free PMC article. Clinical Trial.
Efficacy and safety of guselkumab in patients with active psoriatic arthritis who are inadequate responders to tumour necrosis factor inhibitors: results through one year of a phase IIIb, randomised, controlled study (COSMOS).
Coates LC, Gossec L, Theander E, Bergmans P, Neuhold M, Karyekar CS, Shawi M, Noël W, Schett G, McInnes IB. Coates LC, et al. Among authors: shawi m. Ann Rheum Dis. 2022 Mar;81(3):359-369. doi: 10.1136/annrheumdis-2021-220991. Epub 2021 Nov 24. Ann Rheum Dis. 2022. PMID: 34819273 Free PMC article. Clinical Trial.
Telomerase, senescence and ageing.
Shawi M, Autexier C. Shawi M, et al. Mech Ageing Dev. 2008 Jan-Feb;129(1-2):3-10. doi: 10.1016/j.mad.2007.11.007. Epub 2007 Dec 14. Mech Ageing Dev. 2008. PMID: 18215413 Review.
A Unique Genotype of Pseudohypoaldosteronism Type 1b in a Highly Consanguineous Population.
Alzahrani AS, Alswailem M, Abbas BB, Qasem E, Alsagheir A, Al Shidhani A, Al Sinani A, Al Badi M, Al-Maqbali A, Al Shawi M, Albunyan A, Bin Nafisah A, Shi Y. Alzahrani AS, et al. Among authors: al shawi m. J Endocr Soc. 2021 May 17;5(8):bvab095. doi: 10.1210/jendso/bvab095. eCollection 2021 Aug 1. J Endocr Soc. 2021. PMID: 34258491 Free PMC article.
The rotary mechanism of the ATP synthase.
Nakamoto RK, Baylis Scanlon JA, Al-Shawi MK. Nakamoto RK, et al. Among authors: al shawi mk. Arch Biochem Biophys. 2008 Aug 1;476(1):43-50. doi: 10.1016/j.abb.2008.05.004. Epub 2008 May 20. Arch Biochem Biophys. 2008. PMID: 18515057 Free PMC article. Review.
78 results